Clinical observation during alemtuzumab administration
نویسندگان
چکیده
منابع مشابه
OBSERVATION AND CLINICAL MANIFESTATIONS OF PATIENTS INJURED WITH MUSTARD GAS
More than five hundred chemically injured patients were admitted to the Labbafi-Nejad Medical Center in Spring of 1984. These patients were of two groups. The majority of patients had extensive skin burns, eye injuries as well as respiratory problems, and a second group of patients suffered mainly from neuromuscular and psychological problems. In this report, clinical manifestation and obs...
متن کاملObservation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer
To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic non-small-cell lung cancer, for which gefitinib had been used orally for 3 months or longer, were retrospectively analyzed. The median duration of gefitinib administration was 14 months (3-60 months). Forty pati...
متن کاملUnderstanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
The introduction of high-efficacy therapies for relapsing-remitting multiple sclerosis has driven re-evaluation of treatment goals and benefit:risk considerations in treatment choice. In the alemtuzumab Phase II and III clinical trials, patients treated with alemtuzumab 12 mg versus subcutaneous interferon beta-1a demonstrated significantly reduced annualized relapse rates and improved magnetic...
متن کاملDirect observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy.
Using high-resolution intravital charge-coupled device video microscopy, we visualized the epicardial capillary network of the beating canine heart in vivo to elucidate its functional role under control conditions, during reactive hyperemia (RH), and during intracoronary adenosine administration. The pencil-lens video-microscope probe was placed over capillaries fed by the left anterior descend...
متن کاملAlemtuzumab for Multiple Sclerosis
Alemtuzumab is a humanised anti-CD52 monoclonal antibody approved for use in active, relapsing multiple sclerosis (MS). Administration results in a rapid depletion of circulating lymphocytes with a subsequent beneficial immune reconstitution. Early open-label experience and recent clinical trials have demonstrated a dramatic effect on relapse rates as well as a positive effect on radiological d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Multiple Sclerosis and Related Disorders
سال: 2020
ISSN: 2211-0348
DOI: 10.1016/j.msard.2019.101412